Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3945031 | Gynecologic Oncology | 2012 | 5 Pages |
Abstract
⺠A6 demonstrated minimal activity in this study of recurrent or persistent epithelial ovarian, primary peritoneal, and fallopian tube carcinoma patients. ⺠We were unable to associate CD44 expression with progression free survival at six months.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Michael A. Gold, William E. Brady, Heather A. Lankes, Peter G. Rose, Joseph L. Kelley, Koen De Geest, Marta A. Crispens, Kimberly E. Resnick, Stephen B. Howell,